Correlation Between Prestige Brand and Oasmia Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Prestige Brand and Oasmia Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Prestige Brand and Oasmia Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Prestige Brand Holdings and Oasmia Pharmaceutical AB, you can compare the effects of market volatilities on Prestige Brand and Oasmia Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Prestige Brand with a short position of Oasmia Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Prestige Brand and Oasmia Pharmaceutical.

Diversification Opportunities for Prestige Brand and Oasmia Pharmaceutical

-0.5
  Correlation Coefficient

Very good diversification

The 3 months correlation between Prestige and Oasmia is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Prestige Brand Holdings and Oasmia Pharmaceutical AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oasmia Pharmaceutical and Prestige Brand is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Prestige Brand Holdings are associated (or correlated) with Oasmia Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oasmia Pharmaceutical has no effect on the direction of Prestige Brand i.e., Prestige Brand and Oasmia Pharmaceutical go up and down completely randomly.

Pair Corralation between Prestige Brand and Oasmia Pharmaceutical

Considering the 90-day investment horizon Prestige Brand is expected to generate 1.17 times less return on investment than Oasmia Pharmaceutical. But when comparing it to its historical volatility, Prestige Brand Holdings is 19.35 times less risky than Oasmia Pharmaceutical. It trades about 0.05 of its potential returns per unit of risk. Oasmia Pharmaceutical AB is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  20.00  in Oasmia Pharmaceutical AB on September 4, 2024 and sell it today you would lose (14.00) from holding Oasmia Pharmaceutical AB or give up 70.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy7.68%
ValuesDaily Returns

Prestige Brand Holdings  vs.  Oasmia Pharmaceutical AB

 Performance 
       Timeline  
Prestige Brand Holdings 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Prestige Brand Holdings are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating fundamental drivers, Prestige Brand may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Oasmia Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oasmia Pharmaceutical AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, Oasmia Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Prestige Brand and Oasmia Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Prestige Brand and Oasmia Pharmaceutical

The main advantage of trading using opposite Prestige Brand and Oasmia Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Prestige Brand position performs unexpectedly, Oasmia Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oasmia Pharmaceutical will offset losses from the drop in Oasmia Pharmaceutical's long position.
The idea behind Prestige Brand Holdings and Oasmia Pharmaceutical AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance